Ovarian cancer: an institutional review of patterns of care, health insurance and prognosis
- 31 October 2000
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 36 (16), 2061-2068
- https://doi.org/10.1016/s0959-8049(00)00193-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patientsBJOG: An International Journal of Obstetrics and Gynaecology, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancerThe Lancet, 1998
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Health Insurance and MortalityPublished by American Medical Association (AMA) ,1993
- The Relation between Health Insurance Coverage and Clinical Outcomes among Women with Breast CancerNew England Journal of Medicine, 1993
- Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer: A southwest oncology group studyCancer, 1993
- The impact of subspecialty training on the management of advanced ovarian cancerGynecologic Oncology, 1992
- Socioeconomic status and cancer survival.Journal of Clinical Oncology, 1991
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958